Study Results for Zargis' Cardioscan to be Presented at American Academy of Pediatrics Conference
September 13 2006 - 9:00AM
PR Newswire (US)
Study Co-Author Dr. Reid Thompson of Johns Hopkins University's
School of Medicine to Present a Summary of the Findings PRINCETON,
N.J., Sept. 13 /PRNewswire/ -- Zargis Medical Corp., a spin-off
from Siemens Corporate Research (NYSE:SI) and a majority-owned
subsidiary of Speedus Corp. (NASDAQ:SPDE), today announced that a
summary of the results of the previously announced physician study
conducted in 2005 will be presented at the 2006 American Academy of
Pediatrics (AAP) National Conference & Exhibition. The study,
entitled "The Impact of Computer-Assisted Auscultation on Physician
Recognition and Interpretation of Heart Murmurs", assessed the
impact of Zargis' Cardioscan(R) device on referral decisions made
by primary care physicians regarding heart murmurs-which are
potential indicators of heart disease. The complete study results
have been submitted to a peer-reviewed medical journal for
publication, and a summary of the results will be made available
following the AAP presentation. The AAP is an organization of
60,000 pediatricians committed to the attainment of optimal
physical, mental, and social health and well-being for all infants,
children, adolescents, and young adults. The 2006 AAP National
Conference & Exhibition takes place October 7-10 in Atlanta.
The event serves as a forum at which pediatric professionals from
around the world come together for updates and reviews of pediatric
practice, research, and advocacy. About Zargis Medical Corp. Zargis
Medical Corp. develops advanced diagnostic decision support
products and services for primary care physicians, pediatricians,
cardiologists and other healthcare professionals. Zargis was formed
in 2001 when Siemens Corporate Research, a division of Siemens AG
(NYSE:SI), and Speedus Corp. co-invested to develop and market an
advanced acoustic technology designed to detect heart abnormalities
identified through analysis of heart sounds. About Cardioscan
Zargis has developed Cardioscan, the first and only
computer-assisted medical device designed to support physicians in
analyzing heart sounds for the identification of suspected systolic
and diastolic murmurs. Cardioscan is a non-invasive device that is
easy to use, portable, and takes just minutes to perform. The
device implements voice-guided protocol and a graphical user
interface while maintaining an efficient physician workflow.
Cardioscan provides a summary of findings in terms that are readily
understood by physicians and offers an additional range of
quantitative auscultatory information that cannot be obtained
through listening alone. As a result, Cardioscan enhances
auscultation-a procedure that has been universally employed through
a stethoscope for nearly two-hundred years. For additional
information about Zargis or Speedus Corp., contact Peter Hodge at
888.773.3669 (ext. 23) or or visit the following Web sites:
http://www.zargis.com/ and http://www.speedus.com/. Statements
contained herein that are not historical facts, including but not
limited to statements about the Company's product, corporate
identity and focus, may be forward-looking statements that are
subject to a variety of risks and uncertainties. There are a number
of important factors that could cause actual results to differ
materially from those expressed in any forward- looking statements
made by the Company, including, but not limited to, the continuing
development of the Company's sales, marketing and support efforts.
DATASOURCE: Zargis Medical CONTACT: Peter Hodge of Zargis Medical,
1-888-773-3669 ext. 23, Web site: http://www.speedus.com/
http://www.zargis.com/
Copyright
Speedus (CE) (USOTC:SPDE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Speedus (CE) (USOTC:SPDE)
Historical Stock Chart
From Jul 2023 to Jul 2024